Guilin at forefront in battle against malaria

Chinese company has rolled out a range of artemisinin drugs to combat the disease in South Asia and Africa

A Chinese pharmaceutical company is making major inroads into overseas markets by developing the next generation of drugs to fight malaria.

Guilin Pharmaceutical (Shanghai) Co Ltd, or GPSC, has enhanced its international reputation after rolling out a range of artemisinin products to combat the disease.